Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The prostatic artery (PA) is the primary blood vessel supplying the prostate gland, originating most commonly from the internal pudendal artery. It also provides blood to the urethra, bladder, seminal vesicles, and rectum. Its clinical relevance lies in prostatic artery embolization (PAE), a procedure used to treat benign prostatic hyperplasia (BPH) and, potentially, to manage prostate cancer symptoms prior to radiation therapy by reducing gland size.
Prostatic Artery Embolization (PAE): restricts blood flow to the prostate gland
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostatic Artery (PA).